Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Profit Margin of -133.59% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$41.24M |
|
$-55.09M |
|
$17.93M |
|
$23.31M |
|
$84.77M |
|
$-43.53M |
|
$-12.04M |
|
$-55.58M |
|
$-55.58M |
|
$-55.09M |
|
$-55.09M |
|
$-55.09M |
|
$-55.09M |
|
$-43.53M |
|
$-40.68M |
|
266.20M |
|
266.20M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$366.78M |
|
$59.66M |
|
$156.28M |
|
$523.06M |
|
$98.65M |
|
$143.83M |
|
$397.02M |
|
$495.66M |
|
$27.40M |
|
$9.32M |
|
$27.40M |
|
266.34M |
|
| Cash Flow Statement Financials | |
$-108.92M |
|
$190.04M |
|
$63.12M |
|
$105.64M |
|
$246.90M |
|
$141.27M |
|
$10.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.72 |
|
-- |
|
-- |
|
0.84 |
|
5.25 |
|
56.53% |
|
-105.57% |
|
-105.57% |
|
-- |
|
-134.78% |
|
|
Profit Margin |
-133.59% |
$-113.77M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.51 |
|
1.09 |
|
82.94 |
|
-201.09% |
|
-591.04% |
|
-10.53% |
|
-32.17% |
|
$0.10 |
|
$-0.43 |
|
$-0.41 |
|